Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0040584 (tracheitis)
 384 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

During the last 12 years, 30 cases of tracheopathia chondro-osteoplastica have been diagnosed at the Department of Otolaryngology of Kuopio University. Ten of these were accidentally revealed by bronchoscopy, 2 by autopsy, but 18 were revealed through a systematic examination. Ten of these 18 were preliminarily diagnosed by indirect laryngoscopy. The average age for women was 51 and for men 42, the youngest patient being 11 and the oldest 71 years of age. The characteristic symptoms were long-term recurrent cough, hoarseness and periodic expectoration. The sputum was frequently abundant and crusty, and sometimes contained streaks of blood. Shortness of breath was a common symptom, but there were often entirely asymptomatic periods. The disease begins with a persistent purulent tracheitis, which, probably owing to calciphylaxis, causes accumulation of calcium salts in the tracheal mucosa. Cartilage and bone later develop around these accumulations. In most of the cases of tracheopathia chondro-osteoplastica in the present series, the condition was associated with atrophic rhinitis or pharyngitis. As the nasal disease improves, some regression may occur, though hardly healing. Calcium and phosphorus metabolism was not disturbed, and no immunological aberrations were found in any of the patients in this series.
 ...
PMID:Tracheopathia chondro-osteoplastica. A clinical study of thirty cases. 40 93

The authors evaluate the impact of a synergistic preparation (SP) of supplements (a combination of calcium phosphomycin and tylosine tartarate) on the performance of broilers with a history of carcass condemnation at slaughter. The experiment included 120-day old broilers (Ross 308), divided equally into two treatment groups, with three replicates per treatment and 20 birds per replicate. The two groups included controls that did not receive SP and those that were treated with SP. The SP group received treatment at three intervals (at 1-5 days of age: 160 mg/kg body weight; at 21-25 days of age: 80 mg/kg; and at 29-33 days of age: 80 mg/kg body weight). The administration of SP at a low level improved performance in SP birds compared to controls and also resulted in the lowest cumulative mortality (1.67% vs 6.67%, respectively), the lowest feed conversion of 1.91 between 1 and 43 days of age and the highest live body weight (2,544.75 g vs 2,390.18 g). The administration of SP at a low level improved performance and reduced the frequency of specific gross lesions at market age (tracheitis, lung congestion, breast blisters and bursal congestion).
 ...
PMID:Impact of synergism of calcium phosphomycin/tylosin tartarate supplements on the performance of broilers in the Lebanon. 2039 66